Gossamer Bio GOSS
NASDAQ GOSS
$9.60 +0.14 (+1.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Cash & Current Investments (2018 - 2026)

Updated

Gossamer Bio's Cash & Current Investments came in at $57.03 million for Q2 2026, down 73.2% from $212.92 million a year earlier and down 42.5% from the prior quarter.

Analysis

Gossamer Bio (GOSS) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Gossamer Bio's Cash & Current Investments was $136.93 million, down 53.5% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of -23.2% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $294.52 million in FY2024 (-0.6%), $296.43 million in FY2023 (+15.9%), $255.68 million in FY2022 (-21.4%) and $325.22 million in FY2021 (-36.6%).
  • The Q2 2026 figure represents the lowest quarterly Cash & Current Investments in data going back to Q4 2018.
  • Year-over-year, Cash & Current Investments has declined for five consecutive quarters, with an average decline of 33.6% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2024 (growth of 118.6%), and the weakest in Q2 2026 (a decline of 73.2%).
  • Business Quant data shows GOSS's Cash & Current Investments at $99.22 million (Q1 2026), $136.93 million (Q4 2025) and $180.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Gossamer Bio 38.40 Mn -435.00 Mn - 57.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 57.03 Mn
Mar 31, 2026 99.22 Mn
Dec 31, 2025 136.93 Mn
Sep 30, 2025 180.22 Mn
Jun 30, 2025 212.92 Mn
Mar 31, 2025 257.93 Mn
Dec 31, 2024 294.52 Mn
Sep 30, 2024 327.03 Mn
Jun 30, 2024 354.49 Mn
Mar 31, 2024 244.39 Mn
Dec 31, 2023 296.43 Mn
Sep 30, 2023 328.89 Mn
Jun 30, 2023 162.13 Mn
Mar 31, 2023 201.86 Mn
Dec 31, 2022 255.68 Mn
Sep 30, 2022 304.38 Mn
Jun 30, 2022 222.16 Mn
Mar 31, 2022 271.62 Mn
Dec 31, 2021 325.22 Mn
Sep 30, 2021 366.02 Mn
API Access

Gossamer Bio Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GOSS&period=max&api_key=YOUR_API_KEY